Everolimus in combination with letrozole inhibit human breast cancer MCF-7/Aro stem cells via PI3K/mTOR pathway: an experimental study
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s13277-013-1170-8.pdf
Reference32 articles.
1. Boulay A, Rudloff J, Ye J, et al. Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer. Clin Cancer Res. 2005;11:5319–28.
2. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: International consensus panel of the treatment of primary breast cancer: 7th international conference on adjuvant therapy of primary breast cancer. J Clin Oncol. 2001;19:3817–27.
3. Thürlimann B, Keshaviah A, Coates AS, et al. Breast International Group (BIG) 1–98 Collaborative Group. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med. 2005;353:2747–57.
4. Smith IE, Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med. 2003;348:2431–42.
5. Ghayad SE, Cohen PA. Inhibitors of the PI3K/AKT/mTOR pathway: new hope for breast cancer patients. Recent Pat Anticancer Drug Discov. 2010;5:29–57.
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness;Frontiers in Endocrinology;2023-02-23
2. mTOR pathway as a potential therapeutic target for cancer stem cells in canine mammary carcinoma;Frontiers in Oncology;2023-01-27
3. The Breast Cancer Stem Cells Traits and Drug Resistance;Frontiers in Pharmacology;2021-01-28
4. Anaesthesia and cancer: can anaesthetic drugs modify gene expression?;ecancermedicalscience;2020-07-27
5. c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer: From a Case Report to Patient Cohort Analysis;Targeted Oncology;2020-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3